CD24 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD24 monoclonal antibodies for applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD24 is a glycoprotein that plays a critical role in cell adhesion and signaling, influencing processes such as immune response and tumor progression. Its expression is often associated with various cancers, making CD24 an important target for therapeutic interventions and diagnostic applications. The study of CD24 is essential for understanding its involvement in cellular interactions and its potential as a biomarker in cancer research. CD24 has emerged as a significant molecule in stem cell biology, particularly in the identification and characterization of cancer stem cells. Research has shown that CD24 expression levels can indicate tumor aggressiveness and patient prognosis in several cancer types. Understanding CD24's molecular mechanisms can lead to improved cancer treatments and diagnostic methods. Characterization of CD24 continues to reveal new insights into cellular development and disease progression. Santa Cruz Biotechnology monoclonal antibodies for CD24 support researchers worldwide in advancing scientific understanding of cancer biology and therapeutic development.